AUS
NZ
UK
CA
USA
IND
Highlights:
- The S&P/ASX 200 Health Care (Sector) XHJ was up 0.604% at 38513 points at 12:27 PM AEST today.
- The Healthcare sector comprises several industries such as pharmaceuticals, hospitals, medical equipment & devices, and health insurers.
- The shares of four ASX-listed healthcare stocks, ResMed Inc, CSL Ltd., Cochlear Limited, and Virtus Health Ltd, have been in the news recently.
ASX200 was up 0.108% at 6530.900 points at 11:57 AM AEST today (June 22) after losing nearly 1.21% over the last five days and 11.18% over the last 52 weeks.
The S&P/ASX 200 Health Care (Sector) XHJ was up 0.604% at 38513 points at 12:27 PM AEST. As of 22 June 2022, its year-to-date and one-year returns stand at nearly -16% and -15%, respectively. The healthcare industry has always been very important, and it has been in focus after the Coronavirus pandemic.
The healthcare sector comprises several different industries, including pharmaceuticals, hospitals, medical equipment & devices, and health insurers.
In this article we will discuss four ASX-listed healthcare stocks which have been in focus recently. These four stocks include ResMed Inc (ASX:RMD), CSL Ltd. (ASX:CSL), Cochlear Limited (ASX:COH), and Virtus Health Ltd (ASX:VRT).
Also watch:
ResMed Inc (ASX:RMD)
The share price of medical device company ResMed Inc traded 0.720% lower at AU$28.940 per share on ASX at 1:08 PM AEST today. The company has a market capitalisation of AU$42.67 billion. The company provides cloud-connected medical devices that transform care for people affected with sleep apnea, COPD and other chronic diseases. ResMed falls in the Health Care Equipment & Services industry group. In the last one year, ResMed Inc shares have fallen nearly 9.59%, while the stock is down almost 20.01% year-to-date (YTD).
Read More: QX Resources (ASX:QXR) recommences phase two trenching program at Big Red, shares zoom 9%
Image Source: © Adonis1969 | Megapixl.com
CSL Ltd. (ASX:CSL)
CSL shares traded approx. 0.249% higher at AU$260.66 per share on ASX at 1:13 PM AEST today (June 22). The company has a market capitalisation of AU$125.24 billion. CSL Ltd. falls in the Pharmaceuticals, Biotechnology & Life Sciences industry group. In the last one year, CSL shares have fallen nearly 13.26%, while the stock is down almost 11.94% on YTD. The biotechnology company focuses on rare and serious diseases and influenza vaccines. CSL is also a leading provider of in-licensed vaccines.
Cochlear Limited (ASX:COH)
Cochlear shares were spotted trading 0.616% higher at AU$191.725 per share on ASX at 1:25 PM AEST today. With a market capitalisation of AU$12.53 billion, the company falls in the Health Care Equipment & Services industry group. The share price of Cochlear Limited has fallen nearly 22.33% in the last one year; while the stock is down almost 13.93% YTD.
Virtus Health Ltd (ASX:VRT)
The shares of Virtus Health Ltd were spotted trading 0.383% lower at AU$7.800 per share on ASX at 1:40 PM AEST today. The AU$682.10 million company falls in the Health Care Equipment & Services industry category. In the last one year, Virtus Health shares have gained almost 24%, while the stock is up nearly 15.56% on YTD.
The company is expected to pay a fully franked interim dividend of AU$0.300 per share on 1 July 2022. Earlier this month, Virtus declared that the BGH Bidders had increased the consideration payable to Virtus shareholders under the BGH Offer to $8.155 per Virtus share.
